
Continental AG reported its third-quarter earnings for 2024, with sales reaching €9.83 billion, slightly below the expected €9.97 billion. Despite this, the company's adjusted EBIT was €873 million, surpassing the estimate of €804.4 million, and the adjusted EBIT margin was 8.9%, higher than the anticipated 7.96%. The automotive division generated €4.8 billion in revenue, meeting expectations. However, Continental has revised its full-year sales outlook downwards to between €39.5 billion and €42 billion, citing weak demand from industry clients in Europe and North America. The company also expects earnings at its key automotive unit to improve this quarter as carmakers roll out several new models.
European Premarket Movers Upside - AstraZeneca [$AZN.UK] +2.0-2.5% (Q3 results beat estimates, raises guidance; Submits BLA in US for Dato-DXd; Invests $3.5B for R&D in US) - BMW [$BMW.DE] +0.5% (Morgan Stanley raised to overweight) Downside - SIXT [$SIX2.DE] -4.0% (Q3…
AstraZeneca Raises Outlook on Earnings, Sales Beat https://t.co/Kis0TuUGeP
ASTRAZENECA Q3 24 EARNINGS CORE EPS $2.08 (EST $2.06) || REV. $13.57B (EST $13.08B) || RAISES FY CORE EPS VIEW TO HIGH TEENS PERCENTAGE GROWTH || TO INVEST $3.5B IN R&D AND MANUFACTURING IN THE US || UPGRADES FY GUIDANCE



